| Name | tauroβ-muricholic acid |
|---|---|
| Synonyms |
2-((4R)-4-((3R,5R,6S,7R,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonic acid
Tauro-β-muricholic Acid Tauro-b-muricholic acid beta-Tauromuricholic Acid 5β-CHOLANIC ACID-3α, 6β, 7β, -TRIOL N-(2-SULPHOETHYL)-AMIDE SODIUM SALT tauro-beta-muricholic acid tauromuricholic acid 2-[(3α,6β,7β-Trihydroxy-24-oxo-5β-cholan-24-yl)amino]ethanesulfonic acid Ethanesulfonic acid, 2-[[(3α,5β,6β,7β)-3,6,7-trihydroxy-24-oxocholan-24-yl]amino] Tauro-Beta-muricholic Acid Tauro-β-muricholate 2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid |
| Description | Tauro-β-muricholic acid (TβMCA) is a trihydroxylated bile acid. Tauro-β-muricholic acid is a competitive and reversible FXR antagonist (IC50 = 40 μM). Tauro-β-muricholic acid has antiapoptotic effect. Tauro-β-muricholic acid inhibits bile acid-induced hepatocellular apoptosis by maintaining the mitochondrial membrane potential[1][2]. |
|---|---|
| Related Catalog | |
| Target |
40 μM (FXR)[1] |
| References |
| Molecular Formula | C26H45NO7S |
|---|---|
| Molecular Weight | 515.70300 |
| Exact Mass | 515.29200 |
| PSA | 152.54000 |
| LogP | 3.83980 |